4.7 Article

MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2

Journal

CANCER LETTERS
Volume 363, Issue 2, Pages 146-155

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2015.04.006

Keywords

Nasopharyngeal carcinoma; MiR-93; Dab2; Cell growth; Invasion

Categories

Funding

  1. National Natural Science Foundation of China [81201746, 81402516]
  2. Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]
  3. National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B10]
  4. Science and Technology Project of Guangzhou City, China [14570006]
  5. Planned Science and Technology Project of Guangdong Province [2013B020400004]
  6. Key Laboratory Construction Project of Guangzhou City [121800085]

Ask authors/readers for more resources

Dysregulation of microRNAs (miRNAs) has been demonstrated to contribute to malignant progression in nasopharyngeal carcinoma (NPC). We previously reported that miR-93 was significantly upregulated in NPC based on a microarray analysis. However, the potential role and mechanism of action of miR-93 in the initiation and progression of NPC remain largely unknown. Quantitative RT-PCR demonstrated that miR-93 was significantly upregulated in NPC cell lines and clinical specimens. The MTT assay, colony formation assay, anchorage-independent growth, and Transwell migration and invasion assays showed that depletion of miR-93 inhibited NPC cell growth, invasion and migration in vitro and suppressed tumor growth in vivo. Disabled homolog-2 (Dab2) was verified as a miR-93 target gene using Luciferase reporter assays, quantitative RT-PCR and Western blotting and was involved in miR-93-regulated NPC cell growth, invasion and migration. These results indicated that miR-93 plays an important role in the initiation and progression of NPC by targeting Dab2 and the miR-93/Dab2 pathway may contribute to the development of novel therapeutic strategies for NPC in the future. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available